跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 180 条关于
“CXR101”
全部
180
临床试验
135
药物
31
机构
0
资讯
14
3个月前
Corrixr Therapeutics Names Seagen Veteran Nancy Whiting as Board Chair Ahead of CRISPR Oncology Push
去年
Calluna Pharma's CAL101 Demonstrates Favorable Safety Profile in Phase I Trial for Fibrotic Diseases
去年
Calluna Pharma Appoints Mark Gaffney as CEO, Advances CAL101 Program
11个月前
ClostraBio Launches Next-Generation Probiotic CLB101 and Initiates Clinical Study for Gut Health Applications
去年
China Medical University Achieves Milestone with CAR001 Cell Therapy for Solid Tumors
4个月前
Calluna Pharma Completes Enrollment in Phase 2 AURORA Study of CAL101 for Idiopathic Pulmonary Fibrosis
10个月前
Boehringer Ingelheim Secures $570M Licensing Deal for CDR111 Trispecific T-Cell Engager Targeting Autoimmune Diseases
去年
Gan & Lee's Novel Diabetes Drugs GZR18, GZR4, and GZR101 Achieve Positive Phase 2 Results
去年
Calluna Pharma's CAL101 Demonstrates Favorable Safety Profile in Phase 1 Trial for Fibrotic Diseases
上个月
Ever Supreme's Allogeneic Solid Tumor CAR-T CAR001 Advances to Phase IIa, Targets 2028 Taiwan Provisional Approval
第 1 页,共 2 页
上一页
下一页